CVE-2026-22237
Unauthenticated access to internal API docs may allow abuse of internal APIs.
Is CVE-2026-22237 being exploited?
Not confirmed. CVE-2026-22237 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 0.48% probability of exploitation in the next 30 days.
How severe is CVE-2026-22237?
CVE-2026-22237 is rated Critical with a CVSS score of 10.0. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-22237?
Not known from our data. No patch reference has been recorded for CVE-2026-22237, which is not the same as no patch existing — a fix may have shipped without a tagged reference, or after this record was written. The vendor advisory is the only authority on whether a fix exists, and mitigations may be available regardless.
What does CVE-2026-22237 affect?
CVE-2026-22237 affects BLUVOYIX. Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-22237?
Patch ASAP; restrict API docs exposure
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
Unauthenticated attacker can access internal APIs via crafted HTTP requests, enabling abuse and potential damage.
Patch when possible